divislab glp-1 novo nordisk Novo, Lilly buoyed by fast-growing drug sales Novo Nordisk testing its blockbuster

Vitamin C helps keep glutathione in its active, reduced state, which allows it to continue neutralizing free radicals over a longer period

In the pivotal SURPASS clinical trial program, patients treated with tirzepatide experienced mean reductions in systolic blood pressure ranging from 2 to 8 mmHg compared to baseline

The FDA approved a generic version of Saxenda, also known as liraglutide, in August 2025

Those whose depression improved with treatment (whether SSRIs or therapy) had 30-40% lower risk of developing heart disease, stroke, or dying

Well-designed trials are necessary to examine whether L-carnitine could be helpful in the management of cramps